JPS6412248B2 - - Google Patents
Info
- Publication number
- JPS6412248B2 JPS6412248B2 JP56194344A JP19434481A JPS6412248B2 JP S6412248 B2 JPS6412248 B2 JP S6412248B2 JP 56194344 A JP56194344 A JP 56194344A JP 19434481 A JP19434481 A JP 19434481A JP S6412248 B2 JPS6412248 B2 JP S6412248B2
- Authority
- JP
- Japan
- Prior art keywords
- kallidinogenase
- mixture
- sugar
- weight
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 40
- 102000001399 Kallikrein Human genes 0.000 claims description 28
- 108060005987 Kallikrein Proteins 0.000 claims description 28
- 229960003709 kallidinogenase Drugs 0.000 claims description 28
- 235000000346 sugar Nutrition 0.000 claims description 17
- 239000008101 lactose Substances 0.000 claims description 16
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- 150000005846 sugar alcohols Chemical class 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000006082 mold release agent Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 239000011877 solvent mixture Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229920002261 Corn starch Polymers 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000004922 lacquer Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- -1 Sodium Phosphate Aluminum Magnesium Hydroxide Chemical compound 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000011363 dried mixture Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803045488 DE3045488A1 (de) | 1980-12-03 | 1980-12-03 | Verfahren zur herstellung von stabilisierten kallikreinhaltigen tabletten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57120527A JPS57120527A (en) | 1982-07-27 |
| JPS6412248B2 true JPS6412248B2 (ko) | 1989-02-28 |
Family
ID=6118161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56189371A Granted JPS57120526A (en) | 1980-12-03 | 1981-11-27 | Medicine containing kallikrein and manufacture |
| JP56194344A Granted JPS57120527A (en) | 1980-12-03 | 1981-12-02 | Manufacture of tablets containing stabilized kallikrein |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56189371A Granted JPS57120526A (en) | 1980-12-03 | 1981-11-27 | Medicine containing kallikrein and manufacture |
Country Status (2)
| Country | Link |
|---|---|
| JP (2) | JPS57120526A (ko) |
| DE (1) | DE3045488A1 (ko) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02113842U (ko) * | 1989-02-23 | 1990-09-12 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60161925A (ja) * | 1984-02-02 | 1985-08-23 | Sanwa Kagaku Kenkyusho:Kk | 安定なカリジノゲナーゼ打錠製剤の製法 |
| JPS60169428A (ja) * | 1984-02-15 | 1985-09-02 | Sanwa Kagaku Kenkyusho:Kk | 安定なカリジノゲナーゼ打錠製剤 |
| JPS61180723A (ja) * | 1985-02-06 | 1986-08-13 | Sanwa Kagaku Kenkyusho:Kk | 易吸収性カリジノゲナ−ゼ製剤用組成物 |
| NO852655L (no) * | 1985-06-05 | 1986-12-08 | Bio Data Corp | Fremgangsmaate ved fremstilling av koaguleringsreagens for blodplasma i mikrokonsentrert tablettform. |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| CN112220916A (zh) * | 2020-10-26 | 2021-01-15 | 西南药业股份有限公司 | 生物酶片剂的制备工艺及其产品 |
| CN117180215B (zh) * | 2023-11-07 | 2024-02-02 | 成都通德药业有限公司 | 一种胰激肽原酶肠溶片及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3721725A (en) * | 1970-08-14 | 1973-03-20 | Du Pont | Process for preparing powder blends |
| DE2154557C3 (de) * | 1971-11-03 | 1980-04-10 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von hochreiner Kallidinogenase (Kallikrein) und ein die danach erhaltene kristalline Kallidinogenase enthaltendes Arzneimittel |
-
1980
- 1980-12-03 DE DE19803045488 patent/DE3045488A1/de active Granted
-
1981
- 1981-11-27 JP JP56189371A patent/JPS57120526A/ja active Granted
- 1981-12-02 JP JP56194344A patent/JPS57120527A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02113842U (ko) * | 1989-02-23 | 1990-09-12 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57120526A (en) | 1982-07-27 |
| JPS645578B2 (ko) | 1989-01-31 |
| DE3045488A1 (de) | 1982-07-01 |
| JPS57120527A (en) | 1982-07-27 |
| DE3045488C2 (ko) | 1991-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0305051B1 (en) | Orally sustained-release acetaminophen formulation and process to obtain it | |
| US5006345A (en) | Direct tableting auxiliary | |
| EP0185347B1 (en) | Method for production of stable nicorandil preparation | |
| US10292934B2 (en) | Disintegrating particle composition containing acid-type carboxymethylcellulose and crystalline cellulose, and orally disintegrating tablet containing said composition | |
| JP4748627B2 (ja) | 賦形剤 | |
| EA029890B1 (ru) | Фармацевтическая композиция и фармацевтическая композиция в пероральной дозированной лекарственной форме на основе ингибитора dpp iv | |
| NZ227032A (en) | Stabilised ace inhibitors, a process for their preparation and stable pharmaceutical compositions therefrom | |
| JPS62174013A (ja) | 直打用ビタミン顆粒、その製造法および錠剤 | |
| US20040121006A1 (en) | Utilization of spray-dried powder containing sugar alcohol | |
| CA2371231A1 (en) | Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate | |
| WO2008032767A1 (fr) | Comprimé se désintegrant oralement et procédé de fabrication de celui-ci | |
| KR20150067153A (ko) | 티카그렐러를 함유하는 고형의 경구용 약학 제제 | |
| US8008349B2 (en) | Stable pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers and which is free of organic solvent residues | |
| US20020142044A1 (en) | Pharmaceutical dosage forms with enhanced cohesive and compressiblity properties | |
| CN117122570B (zh) | 一种提高稳定性的美阿沙坦钾片及其制备方法 | |
| JPS6412248B2 (ko) | ||
| US20120010216A1 (en) | Pharmaceutical compositions containing vanoxerine | |
| GB2090739A (en) | Directly compressible acetaminophen granulation | |
| US4753803A (en) | Method for simultaneously drying and granulating extract substances from deproteinized calves blood | |
| US4536511A (en) | Medicaments containing muzolimine, their use and processes for their production | |
| WO2000071117A1 (fr) | Compositions medicinales a liberation immediate pour administration orale | |
| JPH0452252B2 (ko) | ||
| US6322812B1 (en) | Pharmaceutical forms for the oral administration of mesna | |
| RU2281772C1 (ru) | Лекарственная форма, обладающая антиангинальным действием, и способ ее изготовления | |
| JPS60169428A (ja) | 安定なカリジノゲナーゼ打錠製剤 |